Alessandra Mattei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessandra Mattei has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Peng Ding
Department of Statistics, University of California, Berkeley
3 shared publications - Fabrizia Mealli
Department of Economics, European University Institute, 50014 Florence, Italy
2 shared publications - Veronica Ballerini
University of Florence
2 shared publications - Agnese Panzera
DiSIA, University of Florence, Florence, Italy
1 shared publication - Claudio Conversano
Department of Economics and Business Science, University of Cagliari, Cagliari, Italy
1 shared publication - Daniele Vignoli
University of Florence
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Institute of Mathematical Statistics in Bayesian Analysis
- Vol. 20 (3) , 1-28
Assessing Causal Effects in the Presence of Treatment Switching Through Principal Stratification
Clinical trials often allow patients in the control arm to switch to the treatment arm if their physical conditions are worse than certain tolerance levels. For instance, treatment switching arises in the Concorde clinical trial, which aims to assess causal effects on the time-to-disease progression or death of immediate versus deferred treatment with zidovudine among patients with asymptomatic HIV infection. The Intention-To-Treat analysis does not measure the effect of the actual receipt of the treatment and ignores the information on treatment switching. Other existing methods reconstruct the outcome a patient would have had if they had not switched under strong assumptions. Departing from the literature, we re-define the problem of treatment switching using principal stratification and focus on causal effects for patients belonging to subpopulations defined by the switching behavior under control. We use a Bayesian approach to inference, taking into account that (i) switching happens in continuous time; (ii) switching time is not defined for patients who never switch in a particular experiment; and (iii) survival time and switching time are subject to censoring. We apply this framework to analyze the synthetic data based on the Concorde study.
- 1 September 2025
- Published by Institute of Mathematical Statistics in Bayesian Analysis
- Vol. 20 (3) , 1-28
Open AccessAssessing Causal Effects in the Presence of Treatment Switching Through Principal Stratification
Clinical trials often allow patients in the control arm to switch to the treatment arm if their physical conditions are worse than certain tolerance levels. For instance, treatment switching arises in the Concorde clinical trial, which aims to assess causal effects on the time-to-disease progression or death of immediate versus deferred treatment with zidovudine among patients with asymptomatic HIV infection. The Intention-To-Treat analysis does not measure the effect of the actual receipt of the treatment and ignores the information on treatment switching. Other existing methods reconstruct the outcome a patient would have had if they had not switched under strong assumptions. Departing from the literature, we re-define the problem of treatment switching using principal stratification and focus on causal effects for patients belonging to subpopulations defined by the switching behavior under control. We use a Bayesian approach to inference, taking into account that (i) switching happens in continuous time; (ii) switching time is not defined for patients who never switch in a particular experiment; and (iii) survival time and switching time are subject to censoring. We apply this framework to analyze the synthetic data based on the Concorde study.
- 20 June 2025
- Published by Springer Nature
- p. 421-425
Causal Inference Under the Potential Outcomes Approach
- 20 June 2025
- Published by Springer Nature
- p. 421-425
Causal Inference Under the Potential Outcomes Approach
- Open Access
- 19 October 2023
- Published by Springer Nature in Statistical Methods & Applications
- Vol. 32 (4) , 1057-1060
Special issue on Advanced statistical modeling and causal inference with complex data for better decision making
- 19 October 2023
- Published by Springer Nature in Statistical Methods & Applications
- Vol. 32 (4) , 1057-1060
Open AccessSpecial issue on Advanced statistical modeling and causal inference with complex data for better decision making
- Open Access
Selecting Subpopulations for Causal Inference in Regression Discontinuity Designs
The Brazil Bolsa Familia (BF) program is a conditional cash transfer program aimed to reduce short-term poverty by direct cash transfers and to fight long-term poverty by increasing human capital among poor Brazilian people. Eligibility for Bolsa Familia benefits depends on a cutoff rule, which classifies the BF study as a regression discontinuity (RD) design. Extracting causal information from RD studies is challenging. Following Li et al (2015) and Branson and Mealli (2019), we formally describe the BF RD design as a local randomized experiment within the potential outcome approach. Under this framework, causal effects can be identified and estimated on a subpopulation where a local overlap assumption, a local SUTVA and a local ignorability assumption hold. We first discuss the potential advantages of this framework over local regression methods based on continuity assumptions, which concern the definition of the causal estimands, the design and the analysis of the study, and the interpretation and generalizability of the results. A critical issue of this local randomization approach is how to choose subpopulations for which we can draw valid causal inference. We propose a Bayesian model-based finite mixture approach to clustering to classify observations into subpopulations where the RD assumptions hold and do not hold. This approach has important advantages: a) it allows to account for the uncertainty in the subpopulation membership, which is typically neglected; b) it does not impose any constraint on the shape of the subpopulation; c) it is scalable to high-dimensional settings; e) it allows to target alternative causal estimands than the average treatment effect (ATE); and f) it is robust to a certain degree of manipulation/selection of the running variable. We apply our proposed approach to assess causal effects of the Bolsa Familia program on leprosy incidence in 2009.
Open AccessSelecting Subpopulations for Causal Inference in Regression Discontinuity Designs
The Brazil Bolsa Familia (BF) program is a conditional cash transfer program aimed to reduce short-term poverty by direct cash transfers and to fight long-term poverty by increasing human capital among poor Brazilian people. Eligibility for Bolsa Familia benefits depends on a cutoff rule, which classifies the BF study as a regression discontinuity (RD) design. Extracting causal information from RD studies is challenging. Following Li et al (2015) and Branson and Mealli (2019), we formally describe the BF RD design as a local randomized experiment within the potential outcome approach. Under this framework, causal effects can be identified and estimated on a subpopulation where a local overlap assumption, a local SUTVA and a local ignorability assumption hold. We first discuss the potential advantages of this framework over local regression methods based on continuity assumptions, which concern the definition of the causal estimands, the design and the analysis of the study, and the interpretation and generalizability of the results. A critical issue of this local randomization approach is how to choose subpopulations for which we can draw valid causal inference. We propose a Bayesian model-based finite mixture approach to clustering to classify observations into subpopulations where the RD assumptions hold and do not hold. This approach has important advantages: a) it allows to account for the uncertainty in the subpopulation membership, which is typically neglected; b) it does not impose any constraint on the shape of the subpopulation; c) it is scalable to high-dimensional settings; e) it allows to target alternative causal estimands than the average treatment effect (ATE); and f) it is robust to a certain degree of manipulation/selection of the running variable. We apply our proposed approach to assess causal effects of the Bolsa Familia program on leprosy incidence in 2009.
- Open Access
Assessing causal effects in the presence of treatment switching through principal stratification
Clinical trials often allow patients in the control arm to switch to the treatment arm if their physical conditions are worse than certain tolerance levels. For instance, treatment switching arises in the Concorde clinical trial, which aims to assess causal effects on the time-to-disease progression or death of immediate versus deferred treatment with zidovudine among patients with asymptomatic HIV infection. The Intention-To-Treat analysis does not measure the effect of the actual receipt of the treatment and ignores the information on treatment switching. Other existing methods reconstruct the outcome a patient would have had if they had not switched under strong assumptions. Departing from the literature, we re-define the problem of treatment switching using principal stratification and focus on causal effects for patients belonging to subpopulations defined by the switching behavior under control. We use a Bayesian approach to inference, taking into account that (i) switching happens in continuous time; (ii) switching time is not defined for patients who never switch in a particular experiment; and (iii) survival time and switching time are subject to censoring. We apply this framework to analyze synthetic data based on the Concorde study. Our data analysis reveals that immediate treatment with zidovudine increases survival time for never switcher and that treatment effects are highly heterogeneous across different types of patients defined by the switching behavior.
Open AccessAssessing causal effects in the presence of treatment switching through principal stratification
Clinical trials often allow patients in the control arm to switch to the treatment arm if their physical conditions are worse than certain tolerance levels. For instance, treatment switching arises in the Concorde clinical trial, which aims to assess causal effects on the time-to-disease progression or death of immediate versus deferred treatment with zidovudine among patients with asymptomatic HIV infection. The Intention-To-Treat analysis does not measure the effect of the actual receipt of the treatment and ignores the information on treatment switching. Other existing methods reconstruct the outcome a patient would have had if they had not switched under strong assumptions. Departing from the literature, we re-define the problem of treatment switching using principal stratification and focus on causal effects for patients belonging to subpopulations defined by the switching behavior under control. We use a Bayesian approach to inference, taking into account that (i) switching happens in continuous time; (ii) switching time is not defined for patients who never switch in a particular experiment; and (iii) survival time and switching time are subject to censoring. We apply this framework to analyze synthetic data based on the Concorde study. Our data analysis reveals that immediate treatment with zidovudine increases survival time for never switcher and that treatment effects are highly heterogeneous across different types of patients defined by the switching behavior.
- Top Cited PapersOpen Access
- 1 September 2020
- Published by Elsevier in Advances in Life Course Research
- Vol. 45, 100308
The impact of job uncertainty on first-birth postponement
- 1 September 2020
- Published by Elsevier in Advances in Life Course Research
- Vol. 45, 100308
Top Cited PapersOpen AccessThe impact of job uncertainty on first-birth postponement